Taho Pharmaceuticals Ltd. (TPE:6467)
Taiwan · Delayed Price · Currency is TWD 202.50
+15.50 (8.29%)
At close: Oct 22, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 10.61 billion as of October 23, 2026. It is the 17,551st most valuable company in the world and the 694th biggest in Taiwan. Its market cap has increased by 26.31% in one year.
Market Cap
10.61B
Enterprise Value
10.32B
Revenue
1.98M
Global Rank
Country Rank
#694 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 10.61B, an increase of 407.78%. That is a compound annual growth rate of 14.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 10.61B | 85.21% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 7.66B |
| Protect Animal Health | 2.62B |
| TEH SENG Pharmaceutical Mfg. | 2.45B |
| Libo Pharma | 2.18B |
| Anbogen Therapeutics | 1.90B |
| Gin Hwa Biotech Incorporation | 1.77B |
| Timing Pharmaceutial | 1.75B |
| Anya Biopharm | 1.57B |